全文获取类型
收费全文 | 3913篇 |
免费 | 191篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 188篇 |
妇产科学 | 73篇 |
基础医学 | 440篇 |
口腔科学 | 22篇 |
临床医学 | 296篇 |
内科学 | 1145篇 |
皮肤病学 | 68篇 |
神经病学 | 380篇 |
特种医学 | 132篇 |
外科学 | 547篇 |
综合类 | 7篇 |
预防医学 | 131篇 |
眼科学 | 12篇 |
药学 | 303篇 |
中国医学 | 26篇 |
肿瘤学 | 315篇 |
出版年
2023年 | 26篇 |
2022年 | 35篇 |
2021年 | 87篇 |
2020年 | 59篇 |
2019年 | 85篇 |
2018年 | 93篇 |
2017年 | 78篇 |
2016年 | 97篇 |
2015年 | 95篇 |
2014年 | 160篇 |
2013年 | 157篇 |
2012年 | 237篇 |
2011年 | 256篇 |
2010年 | 132篇 |
2009年 | 122篇 |
2008年 | 225篇 |
2007年 | 212篇 |
2006年 | 239篇 |
2005年 | 204篇 |
2004年 | 178篇 |
2003年 | 156篇 |
2002年 | 159篇 |
2001年 | 110篇 |
2000年 | 141篇 |
1999年 | 110篇 |
1998年 | 30篇 |
1997年 | 24篇 |
1996年 | 21篇 |
1995年 | 17篇 |
1994年 | 25篇 |
1993年 | 19篇 |
1992年 | 53篇 |
1991年 | 48篇 |
1990年 | 48篇 |
1989年 | 36篇 |
1988年 | 48篇 |
1987年 | 39篇 |
1986年 | 33篇 |
1985年 | 39篇 |
1984年 | 32篇 |
1983年 | 18篇 |
1982年 | 10篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 18篇 |
1975年 | 12篇 |
1974年 | 9篇 |
1972年 | 10篇 |
1969年 | 10篇 |
1967年 | 11篇 |
排序方式: 共有4130条查询结果,搜索用时 15 毫秒
61.
62.
Defazio G Livrea P Giorelli M Martino D Roselli F Ricchiuti F Trojano M 《Brain research》2000,881(2):227-230
TNFalpha (100 U/ml, 24 h) upregulated intercellular adhesion molecule 1 (ICAM1) expression on brain microvascular endothelial cell (BMEC) culture. The tyrosine kinase (TK) inhibitor genestein (100 microgram/ml), the protein kinase C (PKC) inhibitor staurosporin (1 nM), and interferon (IF) beta-1a (1000 U/ml) antagonized TNFalpha effect. When an ineffective dose of IFbeta-1a (100 U/ml) was challenged with ineffective doses of either genestein (10 microgram/ml) or staurosporin (0.1 nM), the combination IFbeta-1a-genestein significantly reduced TNFalpha-induced ICAM1 expression whereas IFbeta-1a-staurosporin did not. These findings indicate that a TK- rather than a PKC-dependent mechanism is involved in the modulation of TNFalpha response by IFbeta-1a on BMECs. 相似文献
63.
64.
V. Moutardier G. Houvenaeghel M. Martino B. Lelong V. J. Bardou M. Resbeut & J. R. Delpero 《International journal of gynecological cancer》2004,14(5):846-851
Pelvic recurrence of cervical cancer is a life-threatening situation and only local control can provide hope for remission. The aim of this study was to evaluate the role of surgery in the treatment of cervical cancer recurrence. This retrospective study analyzed a series of 70 patients who underwent resection of cervix locoregional recurrence. Thirteen patients had palliative salvage surgery for pelvic complications. Twenty-nine resections were considered as curative. Fifty recurrences required pelvic exenterations. The hospital mortality rate was 9% and the morbidity rate was 44%. Overall 5-year actuarial survival rate was 23%. Survival was significantly higher: (a) after curative resection and (b) after centropelvic recurrence resection. Local control was obtained in 48% of the cases and 13 patients are alive with a median follow-up of 75 months. In conclusion, the results of this small and heterogen series seem to justify an attempt to resection for centropelvic recurrences whenever possible. Palliative surgery should be reserved to salvage therapy and highly selected patients. 相似文献
65.
F Festini E Procopio G Taccetti T Repetto M L Cioni S Campana G Mergni M Mascherini L Marianelli M de Martino 《The journal of maternal-fetal & neonatal medicine》2004,15(6):411-417
OBJECTIVE: To provide centiles for birth weight (BW) according to gestational age (GA) and sex for infants born in Italy. METHODS: We used records of the whole neonatal population of Tuscany, a region in Italy, from July 1991 to June 2002 as resulting from the database of the cystic fibrosis neonatal screening program (n=290129). We excluded as unlikely for GA those BW that were more than two interquartile ranges above the 75th centile or below the 25th centile for each GA and gender group. RESULTS: We present the 3rd, 10th, 25th, 50th, 75th, 90th and 97th centiles of BW for GA from the 24th to 43rd week of gestation for male and female Italian neonates, as both tables and smoothed curves. CONCLUSIONS: The large size of the examined population allows us to provide up-to-date, reliable BW for GA centiles for Italian newborns, especially for lower GAs. 相似文献
66.
Filippo Festini Riccardo Ciuti Giovanni Taccetti Teresa Repetto Silvia Campana Maurizio De Martino 《The journal of maternal-fetal & neonatal medicine》2006,19(6):375-376
We report the case of a 30-year-old woman with cystic fibrosis (CF) chronically infected with Pseudomonas aeruginosa who delivered and breast-fed a healthy boy. While breast-feeding the woman had to undergo an i.v. antibiotic course with tobramycin, due to pulmonary exacerbation. Tobramycin was not detected in her milk and lactation could be continued. This is the first time that the presence of tobramycin in the milk of a CF woman during i.v. administration has been investigated. 相似文献
67.
Comi G Kappos L Clanet M Ebers G Fassas A Fazekas F Filippi M Hartung HP Hertenstein B Karussis D Martino G Tyndall A van der Meché FG 《Journal of neurology》2000,247(5):376-382
Recent reports suggest the possible beneficial effects of haemopoietic stem cell transplantation (HSCT) in autoimmune diseases
such as multiple sclerosis (MS). The definition of the risk/benefit ratio for such a treatment is perceived as a major issue
for the neurological community worldwide. The First Consensus Conference on Bone Marrow Transplantation in Patients with Multiple
Sclerosis was held in Milan, Italy on 21 February 1998. Participants from 16 European, North American, and South American
countries discussed the guidelines form performing HSCT in MS. This conference was organized in order to : (a) define criteria
for patient selection; (b) define transplantation procedures to maximize efficacy of the treatment and minimize its toxicity;
(c) standardize patient outcome evaluation; and (d) establish an international working group to evaluate the efficacy and
safety of HSCT in MS and to study the immunological changes related to HSCT in MS patients. During the meeting in Milan agreement
was reached on: (a) the preparation and distribution of a consensus report on HSCT in MS and (b) the design of an open trial
for an initial assessment of the safety and efficacy of HSCT in MS. The consensus reached during the meeting and the design
of the clinical trial are summarized in this contribution.
Received: 14 May 1999, Received in revised form: 4 January 2000, Accepted: 19 January 2000 相似文献
68.
Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. 总被引:2,自引:0,他引:2
Carol Moreno Neus Villamor Dolors Colomer Jordi Esteve Rodrigo Martino Josep Nomdedéu Francesc Bosch Armando López-Guillermo Elías Campo Jorge Sierra Emili Montserrat 《Journal of clinical oncology》2005,23(15):3433-3438
PURPOSE: To investigate whether allogeneic stem-cell transplantation (allo-SCT) may overcome the negative impact of unmutated VH genes in the outcome of patients with chronic lymphocytic leukemia (CLL). PATIENTS AND METHODS: We analyzed the outcome of patients who underwent SCT according to their VH mutational status. RESULTS: Thirty-four patients (14 allo-SCT and 20 autologous SCT [auto-SCT]) presented unmutated VH genes and 16 patients presented mutated VH genes (nine allo-SCT and seven auto-SCT). Tumoral burden pre-SCT was significantly higher in the allo-SCT patients independent of the VH mutational status. The risk of relapse was significantly higher after auto-SCT (5-year risk, 61%; 95% CI, 44% to 84%) than after allo-SCT (5-year risk 12%, 95% CI, 3% to 44%; P < .05). In the unmutated group, 13 of 20 auto-SCT and two of 14 allo-SCT patients experienced disease progression, with a risk of relapse at 5 years of 66% (95% CI, 48% to 93%) v 17% (95% CI, 5% to 60%), respectively (P = .01). CONCLUSION: These results show that allo-SCT may overcome the unfavorable effect of unmutated VH genes in patients with CLL. 相似文献
69.
Dolores Caballero Jose A García-Marco Rodrigo Martino Victoria Mateos José M Ribera José Sarrá Angel León Guillermo Sanz Javier de la Serna Rafael Cabrera Marcos González Jorge Sierra Jesús San Miguel 《Clinical cancer research》2005,11(21):7757-7763
PURPOSE: To evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis chronic lymphocytic leukemia (CLL) and/or high-risk molecular/cytogenetic characteristics. EXPERIMENTAL DESIGN: Eighty-three percent of patients had active disease at the moment of transplant. That is, 14 of the 23 patients analyzed (60%) had unmutated immunoglobulin variable heavy-chain gene (IgV(H)) status; 8 of 25 patients (32%) had 11q-, with four of them also displaying unmutated IgV(H); and six (24%) had 17p- (five were also unmutated). RESULTS: After a median follow-up of 47.3 months, all 22 patients alive are disease free; overall survival and event-free survival (EFS) at 6 years were 70% and 72%, respectively. According to molecular/cytogenetic characteristics, overall survival and EFS for unmutated CLL and/or with 11q- aberration (n = 13) were 90% and 92%, respectively, not significantly different to those with normal in situ hybridization, 13q- and +12, or mutated CLL (n = 7). All six patients with 17p deletion were transplanted with active disease, including three with refractory disease; all except one reached complete remission after the transplant and two are alive and disease free. Nonrelapse mortality (NRM) was 20%; more than two lines before transplant is an independent prognostic factor for NRM (P = 0,02), EFS (P = 0.02), and overall survival (P = 0.01). Patients older than 55 years have a higher risk of NRM (hazard ratio, 12.8; 95% confidence interval, 1.5-111). Minimal residual disease was monitored by multiparametric flow cytometry in 21 patients. Clearance of CD79/CD5/CD19/CD23 cells in bone marrow was achieved in 68% and 94% of the patients at days 100 and 360, respectively. CONCLUSION: According to these results, RIC allogeneic transplant could overcome the adverse prognosis of patients with unmutated CLL as well as those with 11q- or 17p-. 相似文献
70.
Fabrizio Rao Giancarlo Garuti Michele Vitacca Paolo Banfi Fabrizio Racca Renato Cutrera Martino Pavone Marina Pedemonte Matteo Schisano Stefania Pedroni Jacopo Casiraghi Andrea Vianello Valeria A Sansone UILDM Respiratory group 《Acta myologica》2021,40(1):8
Respiratory complications are common in the patient with muscular dystrophy. The periodic clinical and instrumental respiratory evaluation is extremely important. Despite the presence in the literature of updated guidelines, patient associations often report lack of knowledge of these pathologies, particularly in peripheral hospitals. The purpose of this work, inspired by the Italian Muscular Dystrophy Association (UILDM) is to improve management of respiratory problems necessary for the management of these patients complex. To this end, the main items that the specialist can meet in the follow-up of these pathologies have been analyzed and discussed, among which the respiratory basal evaluation, the criteria of adaptation to non-invasive ventilation, management of bronchial secretions, situations of respiratory emergency, indications for tracheostomy and the subject of advance directives of treatment (DAT).Key words: respiratory failure, muscular dystrophy, cough efficacy, spirometry, polygraphy, non-invasive ventilation, arterial blood gases, cough machine, invasive ventilation, tracheostomy, mechanical ventilation 相似文献